The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information problem. The latest to do so is Google parent company Alphabet, which has established Isomorphic Labs, under DeepMind head Demis Hassabis, to take its […]...
-
Isomorphic Labs is Alphabet’s play in AI drug discovery
techcrunch.com